Master of M&A
29.01.2015 - MedDay Pharmaceuticals has appointed Philippe Goupit as an independent Non-Executive Director on its board of directors. Mr Goupit brings his significant business and corporate development experience in the biotech and pharma sector to the Parisian-based company, which focuses on the treatment of nervous system disorders.
Philippe, a pharma VIP has over 30 years’ experience in the industry, and has spent 20 years at Sanofi. Until recently he was Vice President, Corporate Licenses at Sanofi. His experience in business development covers M&A, as former head of the corporate M&A group in Sanofi, and licensing activities. Philippe has also served for some years as the Head of Investor Relations at Sanofi.
“Philippe’s broad experience will be hugely beneficial to MedDay as the Company continues to develop its pipeline of assets which address areas of unmet need in neurological and psychiatric diseases, through brain metabolism. Through his experience Philippe will contribute to MedDay’s corporate and business development strategy.”http://www.european-biotechnology-news.com/people/bio-people/2015/philippe-goupit.html